CD4 and infection: Spike-specific T cells have been found in SARS-CoV-2 patients, including in mild disease, and 30–50% of healthy people without infection were found to have SARS-Cov2 specific CD4+ and CD8+ cytotoxic T cells [31, 51, 52], possibly HCoV cross-reactive T cells.